Kautzky-Willer A, Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, Prager R, Waldhäusl W
Department of Internal Medicine III, University of Vienna, Austria.
Diabetologia. 2001 Feb;44(2):164-72. doi: 10.1007/s001250051595.
AIMS/HYPOTHESIS: Insulin resistance as well as marked changes in body weight and energy metabolism are associated with pregnancy. Its impact on plasma leptin is not known and was determined in this longitudinal study in both diabetic and normal pregnancy.
At 28 gestational weeks plasma concentrations of leptin and B-cell hormones were measured at fasting and after an oral glucose load (OGTT:75 g) in women with gestational diabetes and pregnant women with normal glucose tolerance and compared with women who were not pregnant (C).
Plasma leptin (ng/ml) was higher (p < 0.001) in women with gestational diabetes (24.9 +/- 1.6) than in women with normal glucose tolerance (18.2 +/- 1.5) and increased in both groups when compared with the non-pregnant women (8.2 +/- 1.3; p < 0.0005). No change in plasma leptin concentrations was induced by OGTT in any group. Basal insulin release was higher (p < 0.05) in women with gestational diabetes compared with the pregnant women with normal glucose tolerance. Marked insulin resistance was confirmed by a 20 % lower (p < 0.05) insulin sensitivity in subgroup analysis and a decrease of almost 40% in fasting glucose/insulin ratio (p < 0.005) in women with gestational diabetes. Leptin correlated in women with gestational diabetes with basal plasma concentrations of glucose (p < 0.02), insulin (p < 0.004) and proinsulin (p < 0.01) as well as with BMI (p < 0.001) and overall pregnancy induced maternal weight gain (p < 0.009). With normalisation of blood glucose 8 weeks after delivery in women with gestational diabetes their plasma leptin decreased (p < 0.0005) to 17.3 +/- 1.9 ng/ml but did not completely normalize (p < 0.05 vs non-pregnant women).
CONCLUSION/INTERPRETATION: Our data show that women with gestational diabetes without any change in plasma leptin upon oral glucose loading have increased plasma leptin concentrations during and after pregnancy, a clear association of plasma leptin with the respective concentration of glucose and insulin resistance as well as with changes in body weight, and a failure to normalize spontaneously BMI to the same extent as pregnant women with normal glucose tolerance when compared with matched control subjects.
目的/假设:胰岛素抵抗以及体重和能量代谢的显著变化与妊娠有关。其对血浆瘦素的影响尚不清楚,本纵向研究在糖尿病妊娠和正常妊娠中对此进行了测定。
在妊娠28周时,测量妊娠期糖尿病妇女和糖耐量正常的孕妇空腹及口服葡萄糖负荷(口服葡萄糖耐量试验:75克)后血浆瘦素和B细胞激素的浓度,并与未怀孕的妇女(对照组)进行比较。
妊娠期糖尿病妇女的血浆瘦素(纳克/毫升)(24.9±1.6)高于糖耐量正常的妇女(18.2±1.5)(p<0.001),与未怀孕妇女(8.2±1.3)相比,两组血浆瘦素均升高(p<0.0005)。口服葡萄糖耐量试验在任何一组中均未引起血浆瘦素浓度的变化。妊娠期糖尿病妇女的基础胰岛素释放高于糖耐量正常的孕妇(p<0.05)。亚组分析显示,妊娠期糖尿病妇女的胰岛素敏感性降低20%(p<0.05),空腹血糖/胰岛素比值降低近40%(p<0.005),证实存在明显的胰岛素抵抗。妊娠期糖尿病妇女的瘦素与基础血浆葡萄糖浓度(p<0.02)、胰岛素浓度(p<0.004)、胰岛素原浓度(p<0.01)、体重指数(p<0.001)以及妊娠引起的孕妇总体重增加(p<0.009)相关。妊娠期糖尿病妇女产后8周血糖恢复正常时,其血浆瘦素降低(p<0.0005)至17.3±1.9纳克/毫升,但未完全恢复正常(与未怀孕妇女相比,p<0.05)。
结论/解读:我们的数据表明,妊娠期糖尿病妇女口服葡萄糖负荷后血浆瘦素无变化,但妊娠期间及产后血浆瘦素浓度升高,血浆瘦素与葡萄糖和胰岛素抵抗的相应浓度以及体重变化明显相关,与糖耐量正常的孕妇相比,妊娠期糖尿病妇女无法将体重指数自发恢复到相同水平。